YD Bio director files initial Form 3

Accepted by SEC EDGAR 04/02/2026 - 04:01 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

YD Bio Ltd director Lu Shao-Ta has filed an initial Form 3 insider ownership report for YD Bio Ltd. The filing lists no reportable transactions or holdings, indicating this is an initial regulatory disclosure of insider status rather than a record of recent trading activity.

Key Figures

Buy transactions: 0 transactions Sell transactions: 0 transactions Reportable holdings entries: 0 entries

3 metrics

Buy transactions 0 transactions Form 3 transactionSummary buyCount

Sell transactions 0 transactions Form 3 transactionSummary sellCount

Reportable holdings entries 0 entries Form 3 transactionSummary holdingEntries

Key Terms

Form 3, reporting person, ten percent owner

3 terms

Form 3 regulatory

"INSIDER FILING DATA (Form 3):"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

reporting person regulatory

"The Form 3 shows that Lu Shao-Ta is now a reporting person"

ten percent owner regulatory

"is_ten_percent_owner: 0"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Lu Shao-Ta’s Form 3 filing for YDES indicate?

The Form 3 shows that Lu Shao-Ta is now a reporting person as a director of YD Bio Ltd (YDES). It is an initial ownership statement and, in this case, shows no reportable transactions or holdings in the provided data.

Did Lu Shao-Ta buy or sell any YD Bio (YDES) shares in this Form 3?

No transactions are reported. The transaction summary lists zero buy, sell, acquire, or dispose events and netBuySellShares of 0, indicating this filing does not reflect recent trading activity in YD Bio shares.

Does the YDES Form 3 show any current holdings for Lu Shao-Ta?

The provided Form 3 data shows holdingEntries of 0, meaning no specific share or derivative positions are listed. It functions solely as an initial insider status disclosure without detailing current holdings in this excerpt.

Is Lu Shao-Ta a ten percent owner of YD Bio Ltd (YDES)?

In this Form 3, the reporting person is marked as a director and not a ten percent owner. The field is_ten_percent_owner is 0, indicating they do not report ownership at or above the 10% threshold here.

Are there any derivative securities reported for YDES in this Form 3?

No derivative positions are shown in the provided data. The derivativeSummary is empty and derivativeTransactionCount is 0, indicating no options, warrants, or other derivatives are reported in this filing excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lu Shao-Ta

(Last) (First) (Middle)

C/O YD BIO LIMITED

12F., NO. 3, XINGNAN ST., NANGANG DIST.

(Street)

TAIPEI CITY HSINCHU COUNTY 115001

(City) (State) (Zip)

TAIWAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
YD Bio Ltd [ YDES ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Shao-Ta Lu	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)